{
  "Variants Include": [
    {
      "Gene": "PINK1",
      "variants": [
        {
          "HGVS": "N.D.",
          "cDNA Change": {
            "transcript": "N.D.",
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Protein Change": {
            "ref": "K",
            "alt": "R",
            "position": "48"
          },
          "Description in input context": "PINK1 K48R mutation"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0013814"
  },
  "Experiment Method": [
    {
      "Assay Method": "Western Blot",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HeLa",
        "Description": "The experiment was conducted using the HeLa cell line."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "N.D.",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "The PINK1 K48R mutation reduced ubiquitin phosphorylation levels by 60% compared to wild-type."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each biological replicate was repeated three times."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": "N.D.",
      "Thresholds for normal readout": {
        "Normal threshold": "Ubiquitin phosphorylation levels above 50% of wild-type control",
        "Source": "Custom"
      },
      "Thresholds for abnormal readout": {
        "Abnormal threshold": "Ubiquitin phosphorylation levels below 30% of wild-type control",
        "Source": "Custom"
      },
      "Approved assay": "Yes"
    },
    {
      "Assay Method": "Immunofluorescence",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HeLa",
        "Description": "Immunofluorescence was performed on HeLa cells to visualize ubiquitin localization."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "N.D.",
          "Conclusion": "Abnormal",
          "Molecular Effect": "altered ubiquitin localization",
          "Result Description": "The PINK1 K48R mutation caused ubiquitin to accumulate in the cytoplasm instead of being localized to mitochondria."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Two biological replicates were performed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each biological replicate was repeated twice."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": "N.D.",
      "Thresholds for normal readout": {
        "Normal threshold": "Ubiquitin localized to mitochondria in >80% of cells",
        "Source": "Custom"
      },
      "Thresholds for abnormal readout": {
        "Abnormal threshold": "Ubiquitin localized to cytoplasm in >50% of cells",
        "Source": "Custom"
      },
      "Approved assay": "Yes"
    }
  ]
}